Literature DB >> 21821732

Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review.

Dan Pugh1, Jack Pugh, Gillian E Mead.   

Abstract

BACKGROUND: the efficacy of warfarin for prevention of stroke in patients with atrial fibrillation (AF) is well established, but many people with AF who would benefit from warfarin are not receiving it. This systematic review aims to determine physicians' attitudes to the prescription of warfarin for AF, and identify reasons for its underuse.
METHODS: an electronic search of MEDLINE (1950-present), EMBASE (1980-present), CINAHL (1994-present), PsycINFO (1987-present) and Web of Knowledge (1970-present) was performed in November 2010 to identify all studies which addressed, via survey, physicians' attitudes regarding anticoagulation for patients with AF.
RESULTS: a total of 1,375 citations were identified. Of these citations, 44 full text studies were obtained for scrutinisation; 14 of these studies were rejected leaving 30 studies which were included in the review. All included studies were cross-sectional surveys and addressed physicians' opinions of anticoagulation in AF as a primary or secondary aim. Increasing age, increased bleeding risk, previous bleeds, falls risk, co-morbidities and ability to comply with treatment influenced whether physicians would prescribe anticoagulation for AF.
CONCLUSION: physicians are reticent to recommend warfarin for elderly patients in AF, despite evidence of increased benefit in these patients compared with younger patients. Risk of falls and previous bleeding were also shown to be disproportionate barriers to warfarin prescription. Further studies are required to determine how best to overcome these perceived barriers to appropriate anticoagulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821732     DOI: 10.1093/ageing/afr097

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  59 in total

1.  "To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists".

Authors:  Francesco Dentali; Nicola Mumoli; Monica Gianni; Marco Cei
Journal:  Intern Emerg Med       Date:  2015-09-02       Impact factor: 3.397

2.  Recurrent Falls Among Elderly Patients and the Impact of Anticoagulation Therapy.

Authors:  Alexander S Chiu; Raymond A Jean; Matthew Fleming; Kevin Y Pei
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

3.  Use of vitamin K antagonist therapy in geriatrics: a French national survey from the French Society of Geriatrics and Gerontology (SFGG).

Authors:  Matthieu Plichart; Gilles Berrut; Nathalie Maubourguet; Claude Jeandel; Jean-Paul Emeriau; Joël Ankri; Hélène Bouvier; Geneviève Ruault; Olivier Hanon
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

4.  Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study.

Authors:  Marco Proietti; Alessandro Nobili; Valeria Raparelli; Laura Napoleone; Pier Mannuccio Mannucci; Gregory Y H Lip
Journal:  Clin Res Cardiol       Date:  2016-05-31       Impact factor: 5.460

5.  Effects of "Fit fOR The Aged" (FORTA) on pharmacotherapy and clinical endpoints--a pilot randomized controlled study.

Authors:  Carina Michalek; Martin Wehling; Jeanina Schlitzer; Helmut Frohnhofen
Journal:  Eur J Clin Pharmacol       Date:  2014-08-17       Impact factor: 2.953

Review 6.  Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future.

Authors:  Ramsey M Wehbe; Ajay Yadlapati
Journal:  Tex Heart Inst J       Date:  2016-08-01

7.  Implementing a screening tool to improve prescribing in hospitalized older patients: a pilot study.

Authors:  Anne-Laure Sennesael; Olivia Dalleur; Séverine Henrard; Charline Artoisenet; Didier Schoevaerdts; Anne Spinewine
Journal:  Int J Clin Pharm       Date:  2017-11-23

Review 8.  Dabigatran etexilate: appropriate use in patients with chronic kidney disease and in the elderly patients.

Authors:  Mauro Molteni; Mario Bo; Giovanni Di Minno; Giuseppe Di Pasquale; Simonetta Genovesi; Danilo Toni; Paolo Verdecchia
Journal:  Intern Emerg Med       Date:  2017-04-24       Impact factor: 3.397

9.  Anticoagulant use for prevention of stroke in a commercial population with atrial fibrillation.

Authors:  Aarti A Patel; Barb Lennert; Brian Macomson; Winnie W Nelson; Gary M Owens; Samir H Mody; Jeff Schein
Journal:  Am Health Drug Benefits       Date:  2012-07

Review 10.  Oral anticoagulants in older adults with atrial fibrillation.

Authors:  Gwen M Bernacki; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.